Investor Relations

At Alere, our mission is to empower individuals to take charge of their own health under medical supervision, to enable healthcare providers to improve clinical outcomes and lower costs, and to deliver significant annual earnings growth to our investors over the next several years.  We strive to build open relationships with our shareholders and prospective investors, and we manage these relationships in accordance with company policies and relevant securities law.

A global leader in rapid point-of-care diagnostics, our products, as well as our new product development efforts, focus on cardiology, infectious disease, women's health, oncology, and toxicology. Being a leading developer of innovative diagnostic and monitoring devices allows us to combine near-patient monitoring tools with value-added healthcare services in order to improve care and lower healthcare costs for both providers and patients.